Perhaps our best hope then is for diagnostics companies to sell POCT
"packages" to pharmacies etc as they do with glucose meters to hospitals
- costs to include user training, QC materials and membership of an EQA
scheme, along with consumables.
It would certainly be worth their while doing so, and ensuring that
quality procedures were followed, as having their product(s) involved in
a court case following a patient tragedy would be the last thing they'd
want.
Dr MJ Pearson
Department of Clinical Biochemistry & Immunology
Old Medical School
Leeds General Infirmary (Leeds Teaching Hospitals NHS Trust)
LEEDS LS1 3EX
UK
tel (44)-113-392-3945
fax (44)-113 392-3453.
http://www.leedsth.nhs.uk
>>> "Williams David G (RLN) City Hospitals Sunderland - Clinical
Scientist" <[log in to unmask]> 13/08/2007 16:24
>>>
Having discussed the matter with our local pharmacists, the following
may be
of interest:-
4. In amongst all of this, there seems to be no discussion of the
quality of
results.
I suspect that commercial POCT providers may well escape the need for
EQAS
etc, until, that is, the first few cases of litigation.
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|